局所コルチコステロイドの市場規模・シェア・展望・機会 (2022年～2030年)：製剤・用途・流通チャネル・地域別

参入事業者はジェネリック製品の発売に注力しており、予測期間中の世界の局所コルチコステロイド (ステロイド) 市場の成長に寄与すると予測されています。また、企業による買収などの戦略、湿疹のより良い治療のためのイニシアチブの増加なども予測期間中の市場成長を助けると予想されています。

当レポートでは、世界の局所コルチコステロイド (ステロイド) の市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、法規制・償還環境、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 調査目的・前提条件

第2章 市場概要

第3章 市場力学・規制・動向分析

• 市場力学
  • 促進要因
  • 抑制要因
  • 市場機会
• 影響分析
• ポーターの分析
• 産業動向
• 主なハイライト
• 疫学
• 償還シナリオ
• 規制シナリオ
• 製品の発売・承認
• 買収・提携シナリオ

第4章 世界の局所コルチコステロイド (ステロイド) 市場：COVID-19の影響

• COVID-19：疫学
• 局所コルチコステロイドの需要と供給に対するCOVID-19の影響
• ヘルスケア部門全体に対するCOVID-19の影響

第5章 世界の局所コルチコステロイド (ステロイド) 市場：製剤別

• クリーム
• 軟膏
• ジェル
• その他

第6章 世界の局所コルチコステロイド (ステロイド) 市場：用途別

• にきび
• 皮膚炎
• 乾癬
• 湿疹
• 色素沈着過剰
• その他

第7章 世界の局所コルチコステロイド (ステロイド) 市場：流通チャネル別

• 病院薬局
• 小売薬局
• オンライン薬局

第8章 世界の局所コルチコステロイド (ステロイド) 市場：地域別

• 北米
• ラテンアメリカ
• 欧州
• アジア太平洋
• 中東
• アフリカ

第9章 競合情勢

• 企業プロファイル
  • GlaxoSmithKline plc
  • Merck &Co., Inc.
  • Sandoz International GmbH
  • AstraZeneca
  • LEO Pharma
  • Cipla Inc.
  • Bristol-Myers Squibb Company
  • Almirall, SA
  • Bausch Health
  • Sanofi SA

第10章 セクション

Topical steroids are available in a variety of strengths and are classified into seven classes based on their potency. Class I (class one) contains the strongest steroids, while Class VII contains the weakest (class seven).

Topical steroids in Class I are 600 to 1,000 times more powerful than those in Class VII. The right steroid strength, or potency, is determined by a number of factors.

Babies, for example, absorb topical steroids much faster than adults, so a low-potency steroid may be required.

Topical steroids are absorbed quickly in parts of the body where skin touches flesh, such as the armpits or beneath the breasts, or in sensitive areas of skin, such as the eyelids, and may only require a low-potency formulation.

Market Dynamics

Market players are focused on launching generic products, this is expected to contribute to growth of the global topical corticosteroids (steroids) market over the forecast period. For instance, in March 2019, Lupin Limited, an Indian pharmaceutical company announced the launch of Fluocinonide Ointment USP, 0.05 %, which was approved by the US Food and Drug Administration (FDA) in July 2018. Lupin's Fluocinonide Ointment USP, 0.05% is the generic equivalent of County Line Pharmaceuticals LLC's Lidex Ointment 0.05%. It is used to treat inflammatory and pruritic symptoms associated with corticosteroid-responsive dermatoses.

Market players are involved in strategies such as acquisitions, which is expected to contribute to growth of global topical corticosteroids (steroids) market. For instance, in October 2018, Mayne Pharma, a specialty pharmaceutical company, announced that it has acquired the US and Australia rights to halobetasol foam 0.05% for US$32.0 million. Halobetasol foam is a highly potent corticosteroid that is used to treat plaque psoriasis.

Increasing initiatives by non-profit organizations for better treatment of eczema is expected to aid growth of the global topical corticosteroids (steroids) market over the forecast period. For instance, in September 2021, on world eczema day (September 14), eleven patient organizations from eight countries came together to launch the Global Patient Initiative to Improve Eczema Care (GPIIEC). The programme is a global effort to develop a uniform "yardstick" for evaluating how well health systems respond to demands of patients and their caregivers. This groundbreaking collaboration has discovered aspects of health-care delivery that matter most to patients and caregivers, as well as indicators to assess them across eight developed countries (Australia, Canada, Denmark, France, Italy, Germany, United States, and the United Kingdom).

Key features of the study:

• This report provides an in-depth analysis of global topical corticosteroids (steroids) market , provides market size (US$ Billion), and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
• It profiles leading players in the global topical corticosteroids (steroids) market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
• Key companies covered as a part of this study include GlaxoSmithKline plc, Merck & Co., Inc., Sandoz International GmbH, AstraZeneca, LEO Pharma, Cipla Inc., Bristol-Myers Squibb Company, Almirall, S.A., Bausch Health, and Sanofi SA
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
• The global topical corticosteroids (steroids) market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global topical corticosteroids (steroids) market.

Detailed Segmentation:

• Global Topical Corticosteroids (steroids) Market , By Formulation:
  • Creams
  • Ointments
  • Gels
  • Others (solutions, foams, spray, etc.)
• Global Topical Corticosteroids (steroids) Market , By Application:
  • Acne
  • Dermatitis
  • Psoriasis
  • Eczema
  • Hyperpigmentation
  • Others (rash, etc.)
• Global Topical Corticosteroids (steroids) Market , By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Global Topical Corticosteroids (steroids) Market , By Region:
  • North America
    • By Country:
    • U.S.
    • Canada
  • Latin America
    • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • By Country:
    • U.K.
    • Germany
    • Italy
    • Spain
    • France
    • Russia
    • Rest of Europe
  • Asia Pacific
    • By Country
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • By Country:
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
• Company Profiles
  • GlaxoSmithKline plc*
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
  • Merck & Co., Inc.
  • Sandoz International GmbH
  • AstraZeneca
  • LEO Pharma
  • Cipla Inc.
  • Bristol-Myers Squibb Company
  • Almirall, S.A.
  • Bausch Health
  • Sanofi SA

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Overview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Formulation
  • Market Snippet, By Application
  • Market Snippet, By Distribution channel
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Porter's Analysis
• Industry Trends
• Key Highlights
• Epidemiology
• Reimbursement Scenario
• Regulatory Scenario
• Product Launch and Approvals
• Acquisition and Collaboration Scenario

4. Global Topical Corticosteroids (steroids) Market - Impact of Coronavirus (Covid-19) Pandemic

• COVID-19 Epidemiology
• Impact of COVID-19 on Demand and Supply of Topical Corticosteroids
• Impact of COVID-19 on the overall Healthcare Sector

5. Global Topical Corticosteroids (steroids) Market , By Formulation, 2017-2030 (US$ Billion)

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Creams
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
• Ointments
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
• Gels
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)

6. Global Topical Corticosteroids (steroids) Market , By Application, 2017-2030 (US$ Billion)

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Acne
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
• Dermatitis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
• Psoriasis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
• Eczema
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
• Hyperpigmentation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)

7. Global Topical Corticosteroids (steroids) Market , By Distribution Channel, 2017-2030 (US$ Billion)

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)

8. Global Topical Corticosteroids (steroids) Market , By Region, 2017-2030 (US$ Billion)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2018-2030
  • Regional Trends
• North America
  • Market Size and Forecast, By Formulation, 2017-2030 (US$ Bn)
  • Market Size and Forecast, By Application, 2017-2030 (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Bn)
  • Market Size and Forecast, By Country, 2017-2030 (US$ Bn)
  • U.S.
  • Canada
• Latin America
  • Market Size and Forecast, By Formulation, 2017-2030 (US$ Bn)
  • Market Size and Forecast, By Application, 2017-2030 (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Bn)
  • Market Size and Forecast, By Country, 2017-2030 (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Market Size and Forecast, By Formulation, 2017-2030 (US$ Bn)
  • Market Size and Forecast, By Application, 2017-2030 (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Bn)
  • Market Size and Forecast, By Country, 2017-2030 (US$ Bn)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • Market Size and Forecast, By Formulation, 2017-2030 (US$ Bn)
  • Market Size and Forecast, By Application, 2017-2030 (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Bn)
  • Market Size and Forecast, By Country, 2017-2030 (US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • Market Size and Forecast, By Formulation, 2017-2030 (US$ Bn)
  • Market Size and Forecast, By Application, 2017-2030 (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Bn)
  • Market Size and Forecast, By Country/Region, 2017-2030 (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • Market Size and Forecast, By Formulation, 2017-2030 (US$ Bn)
  • Market Size and Forecast, By Application, 2017-2030 (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Bn)
  • Market Size and Forecast, By Country/Region, 2017-2030 (US$ Bn)
  • South Africa
  • Central Africa
  • North Africa

9. Competitive Landscape

• Company Profiles
  • GlaxoSmithKline plc*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Merck & Co., Inc.
  • Sandoz International GmbH
  • AstraZeneca
  • LEO Pharma
  • Cipla Inc.
  • Bristol-Myers Squibb Company
  • Almirall, S.A.
  • Bausch Health
  • Sanofi SA

Key pointers provided are also applicable to other companies covered in the scope of the report.

10. Section

• Research Methodology
• About us
• Contact